Sara, Roderick R.

HRN: 28-69-07  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/19/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/19/2026
03/26/2026
IV
1.5mg
Q8hrs
DM FOOT
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines